PubMed ID:
21483459
Public Release Type:
Journal
Publication Year: 2011
Affiliation: Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109, USA. whasler@umich.edu
DOI:
https://doi.org/10.1038/ajg.2011.81
Authors:
Van Raaphorst R,
Torrance R,
James S,
Ameen V,
Hamilton F,
Stuart P,
Menon L,
Hooker J,
Culler S,
Calles J,
Baxter L,
Koch KL,
Spree D,
Smith M,
McNair V,
Kedar A,
Hynes P,
Henry O,
Fordham J,
Abell TL,
Atkinson M,
Hasler WL,
Simmons K,
Sachdeva P,
Palit A,
Lytes V,
Kantor S,
Parkman HP,
Bernard C,
Farrugia G,
Shetler K,
Parker S,
Louiseau S,
Greene M,
DeVole N,
Snape WJ,
Ullah N,
Nguyen L,
Pasricha PJ,
NIDDK Gastroparesis Clinical Research Consortium (GpCRC),
Hamilton F,
Unalp-Arida A,
Tonascia J,
Lee L,
Farrugia G,
Snape WJ,
Pasricha PJ,
Koch KL,
Abell TL,
Nguyen L,
Parkman HP,
Wilson LA,
Hasler WL,
Kim W,
Lee L,
Miriel L,
Sternberg A,
Ünalp-Arida A,
Van Natta M,
Vaughn I,
Wilson L,
Yates K,
Tonascia J,
Belt P,
Colvin R,
Donithan M,
Green M,
Isaacson M
Studies:
Gastroparesis Clinical Research Consortium
,
Nortriptyline for Idiopathic Gastroparesis
Bloating is commonly reported in gastroparesis, but its prevalence, impact, and associated factors are uninvestigated. We aimed to quantify the prevalence of bloating in gastroparesis and relate its severity to clinical factors and quality of life.